Cargando…
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
PURPOSE: Low expression of HER2 (HER2-low expression) in breast cancer (BC) has unique biological characteristics. However, whether HER2-low expression has an impact on neoadjuvant chemotherapy (NACT) in HER2-negative breast cancer remains unclear. METHODS: This study reviewed the clinicopathologica...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202994/ https://www.ncbi.nlm.nih.gov/pubmed/36586066 http://dx.doi.org/10.1007/s12094-022-03062-9 |